|
|
| (11) | Number of the document | |
| (68) | Number of the document | 4176894 |
| (21) | Application number for Supplementary Protection Certificate | PA 2024 536 |
| (22) | Date of filing the application | 2024-12-13 |
| (41) | Date of publication of the application | 2025-01-10 |
| Date of publication of SPC | ||
| (24) | Date of coming into effect of SPC |
| (71) |
Bioverativ Therapeutics Inc. ,
225 Second Avenue, Waltham MA 02451,
US
|
| (73) |
Bioverativ Therapeutics Inc. ,
225 Second Avenue, Waltham MA 02451,
US
|
| (74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (93) | EU/1/24/1824, 2024-06-17 |
| (95) | Efanesoktokogas alfa arba panašus biologinis medicinos produktas, apsaugotas pagrindiniu patentu |
| SPC application published |